TY - JOUR T1 - Longitudinal association between lung function and health-related quality of life in cystic fibrosis JF - Thorax JO - Thorax SP - 149 LP - 154 DO - 10.1136/thoraxjnl-2012-202552 VL - 68 IS - 2 AU - Janice Abbott AU - Margaret A Hurley AU - Alison M Morton AU - Steven P Conway Y1 - 2013/02/01 UR - http://thorax.bmj.com/content/68/2/149.abstract N2 - Background Lung function is an important indicator of cystic fibrosis disease status and those with better forced expiratory volume in 1 s (FEV1)% predicted have tended to report a better health-related quality of life (HRQoL) in cross-sectional studies. The relationship between lung function and HRQoL over time is unknown. This work assesses the natural progression of HRQoL reporting over many years and compares assessments across a whole decade and evaluates the relationship between lung function and HRQoL longitudinally. Methods Demographic (age, gender), clinical (FEV1% predicted, body mass index, diabetes, Burkholderia cepacia complex, intravenous access device and nutritional status) and HRQoL (Cystic Fibrosis Quality of Life Questionnaire) variables were obtained every 2 years over a 12-year period (seven time points from 1998 to 2010). Results HRQoL and lung function declined slowly over time and significant decade changes were observed for FEV1% predicted and the nine domains of the Cystic Fibrosis Quality of Life Questionnaire. The results of random coefficient modelling indicated that, at the population level, decreasing FEV1% predicted was associated with decreasing HRQoL after adjusting for confounding variables. However, the percentage of patients for whom a decrease in lung function was associated with a decrease in HRQoL differed according to the quality of life domain. Conclusions HRQoL and FEV1% predicted decline slowly; nevertheless, a decrease in lung function predicted a decrease in HRQoL over time. ER -